<DOC>
	<DOCNO>NCT02781922</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety intracoronary injection JRM-001 reconstructive surgery pediatric patient functional single ventricle</brief_summary>
	<brief_title>Cardiac Stem/Progenitor Cell Infusion Univentricular Physiology ( APOLLON Trial )</brief_title>
	<detailed_description />
	<mesh_term>Hypoplastic Left Heart Syndrome</mesh_term>
	<criteria>Functional single ventricle patient heart failure schedule stage 2 ( Glenn ) stage 3 ( Fontan ) surgery EF ( % ) echocardiography â‰¤ 55 % Able obtain write informed consent participation study parent patient Known medical history cardiogenic shock Lethal , uncontrollable arrhythmia Complication coronary artery disease Eisenmenger syndrome Complication brain dysfunction due circulatory failure Malignant neoplasm Complication severe neurologic disorder Severe pulmonary embolism pulmonary hypertension Severe renal failure Multiple organ failure Active infection ( include endocarditis ) Sepsis Active hemorrhagic disease ( e.g . gastrointestinal bleeding , injury ) Known history hypersensitivity antiinfective drug Inability complete protocol treatment baseline followup examination</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>cardiac stem/progenitor cell</keyword>
	<keyword>autologous cell therapy</keyword>
	<keyword>functional single ventricle</keyword>
	<keyword>congenital heart disease</keyword>
</DOC>